Who
Ivor Elrifi
Chief Executive Officer
Company insider
Files Form 4 as: Chief Executive Officer, Tiziana Life Sciences.
In numbers
- Trades disclosed
- 10
- Buys
- 3
- Sells
- 0
- Bought
- $2.0M
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 3 Aug 2026
- Last trade
- 15 Aug 2026
- Last filed
- 29 Sep 2026
Companies traded
Activity over time
1 Aug – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Aug 2026filed 29 Sep 2026 | TLSA Tiziana Life SciencesBiotechnology | SEC FORM 4 Code M | —1,050,000 | filing |
| 15 Aug 2026filed 29 Sep 2026 | TLSA Tiziana Life Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,050,000 | filing |
| 15 Aug 2026filed 29 Sep 2026 | TLSA Tiziana Life Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,050,000 | filing |
| 15 Aug 2026filed 29 Sep 2026 | TLSA Tiziana Life SciencesBiotechnology | SEC FORM 4 Code M | —1,050,000 | filing |
| 5 Aug 2026filed 6 Aug 2026 | TLSA Tiziana Life SciencesBiotechnology | SEC FORM 4 Bought | $238K237,616 at $1.00 | filing |
| 5 Aug 2026filed 6 Aug 2026 | TLSA Tiziana Life SciencesBiotechnology | SEC FORM 4 Bought | $238K237,616 at $1.00 | filing |
| 4 Aug 2026filed 6 Aug 2026 | TLSA Tiziana Life SciencesBiotechnology | SEC FORM 4 Bought | $81K83,807 at $0.97 | filing |
| 4 Aug 2026filed 6 Aug 2026 | TLSA Tiziana Life SciencesBiotechnology | SEC FORM 4 Bought | $81K83,807 at $0.97 | filing |
| 3 Aug 2026filed 5 Aug 2026 | TLSA Tiziana Life SciencesBiotechnology | SEC FORM 4 Bought | $667K667,000 at $1.00 | filing |
| 3 Aug 2026filed 5 Aug 2026 | TLSA Tiziana Life SciencesBiotechnology | SEC FORM 4 Bought | $667K667,000 at $1.00 | filing |
News
Tiziana Life Sciences Ltd.: Tiziana Management Team to Attend the 10th Joint ACTRIMS-ECTRIMS Meeting in TorontoTLSA · finanznachrichten.de · 21 Oct 2026Tiziana Life Sciences Ltd.: Tiziana Doses Last Patient in Phase 2 Trial of Intranasal Foralumab for Mild Alzheimer's DiseaseTLSA · finanznachrichten.de · 16 Oct 2026
0 headlines in the last 90 days name Ivor Elrifi; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.